Trial intelligence / Profile preview

Pre-operative RASI vs CCB for Hypotension in Carotid Artery Stenting

NCT05905848Phase 3Unknown

Sponsor
West China Hospital of Sichuan University
Start
Jun 2023
Primary completion
May 2025
Countries
1
01

Overview

Phase 3, randomised, open-label trial in hypertension (HTN), sponsored by West China Hospital of Sichuan University. Primary endpoint: Incidence of persistent post-surgery hypotension at 24 hours. Status: unknown.

02

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT05905848.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05905848.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call